Mandate

Vinge advises in conjunction with the sale of Astrego Diagnostics to Sysmex

May 02, 2022 M&A

Vinge has advised the main owners of Astrego Diagnostics AB in conjunction with the sale of the shares to the Japanese minority owner, Sysmex Corporation.

Astrego has developed a diagnostic tool for determining the presence of bacteria in patient samples and the determination of resistance against different antibiotics (so-called ”Antibiotic Susceptibility Test, AST”).

Vinge’s team consisted of Johan WinnerbladEléonore FribergViktoria Owetz Leyva and Gunilla Nyman.

Related

Vinge has advised Stendörren Fastigheter in connection with a directed share issue of approximately SEK 300 million

Vinge has advised the property company Stendörren Fastigheter AB (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 300 million before transaction costs.
May 14, 2025

Vinge has advised EQT AB in connection with its bond issue in the aggregate principal amount of USD 500,000,000

EQT AB (publ) has issued senior bonds in the aggregate principal amount of USD 500,000,000 with an interest rate of 5.850%, due 2035, at a price equal to 99.783% of the aggregate principal amount thereof.
May 13, 2025

Vinge has advised Qlik in connection with acquisition

Vinge has advised the Qlik Group in connection with its acquisition of the Qloud Cover Migration technology from Stretch Qonnect. This automated solution, to be branded as the Qlik Analytics Migration Tool, eliminates the complexity of migrating from QlikView, Qlik Sense, and NPrinting to Qlik Cloud – a persistent barrier to cloud adoption.
May 13, 2025